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Abstract
Background: There are few reports about work-related factors associated with Sjögren’s syndrome. We report a
case of overlap syndrome with Sjögren’s syndrome and systemic sclerosis.
Case presentation: A 54-year-old man was admitted due to dyspnea on exertion. The results of physical
examination and laboratory findings were compatible with Sjögren’s syndrome with systemic sclerosis. The patient
had no pre-existing autoimmune disease, and denied family history of autoimmune disease. The patient worked in
the large-scale rolling department of a steel manufacturing company for 25 years. Hot rolling is a rolling process
performed at between 1100 °C and 1200 °C, generating a high temperature and a large amount of fumes, involving
jet-spraying of water throughout the process to remove the instantaneously generated oxide film and prevent the
high generation of fumes. In this process, workers could be exposed to silica produced by thermal oxidation. Other
potential toxic substances including nickel and manganese seemed to be less likely associated with the patient’s
clinical manifestations.
Conclusions: Occupational exposure to silica seemed to be associated with the patient’s clinical manifestations of
overlap syndrome with Sjögren’s syndrome and systemic sclerosis. Although the underlying mechanism is still
unclear, autoimmune disease including Sjögren’s syndrome affects women more often than men and there was no
family history of autoimmune disease. These suggested that there was an association between occupational silica
exposure and the disease of the patient. Future research about the association between long-term low dose
exposure to silica and the development of autoimmune diseases should be encouraged.
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Background
Connective tissue diseases are systemic autoimmune dis-
eases characterized by the appearance of a variety of
symptoms and organ infiltration [1]. Although widely ac-
cepted classification standards exist for each disease,
some undifferentiated connective tissue diseases are dif-
ficult to classify. Overlap syndrome is a condition in
which the patient develops symptoms corresponding to
two or more classification standards [2]. Although over-
lap syndrome can cause confusion during diagnosis, it is
important because it can provide clues to the causes and
pathogenic mechanisms of related diseases. Sjögren’s
syndrome is an autoimmune exocrinopathy, in which
systemic diseases, such as arthritis, interstitial lung dis-
ease, and kidney disease, can develop in addition to
characteristic dry eye and mouth symptoms [3]. Sjög-
ren’s syndrome occurs more frequently in female pa-
tients patients than in male patients, especially in
middle-aged women. Although the prevalence rate is
known to be 0.5–1 %, no accurate reports are present on
the prevalence rate in Korea. Sjögren’s syndrome was
first described by Johann Mikulicz in 1892 as “Mikulicz’s
syndrome” after discovery of the infiltration of small,
round cells into the salivary glands of a 42-year-old
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farmer with bilateral parotid gland enlargement. In 1933,
a Swedish ophthalmologist, Henrik Sjögren, first used
the term “keratoconjunctivitis sicca” to describe the dry
eye symptom in 13 patients with accompanying rheuma-
toid arthritis among 19 patients with dry eye and mouth
symptoms, differentiating it from “xerophthalmia,” the
dry eye symptom due to vitamin A deficiency [4].
Although there have been some reports caused by sil-
ica, these are considered to be rare [5]. Systemic
sclerosis is a disease characterized by lymphocyte de-
position and fibrosis of various organs, with fibrosis
developing mainly in the skin, kidney, heart, lungs,
and digestive system. Lung infiltration occurs in 70 %
of systemic sclerosis patients [6], and although the
precise cause of the disease has not been identified, it
is known that endothelial cells are damaged and fi-
broblasts are activated by an autoantibody-mediated
immunological mechanism [7]. Here, we report the
case of a steel rolling mill worker with overlapping
features of Sjögren’s syndrome and systemic sclerosis.
Case presentation
Patient information
Fifty-four year old male
Chief complaints
The chief complaint of the patient included breathing
difficulty and coughing during exercise that developed
2 months previously.
Current disease history
Breathing difficulty and coughing aggravated further
during mountain hiking. A pulmonary disease was sus-
pected from the findings of chest radiographs. The pa-
tient was hospitalized to obtain an accurate diagnosis
and for treatment.
Past medical history
On a special health examination performed 5 months
before admission, no unusual findings were observed
on the plain chest radiography. The patient had no
ophthalmologic diseases, but complained of eye dry-
ness for several months. He frequently used artificial
tears because of the eye dryness.
Personal history
The patient had a history of smoking 20 cigarettes a
day for 20 years and then 10 cigarettes a day for
10 years; however, he quit smoking 3 months previ-
ously. He has a history of consuming five bottles
(350 mL) of soju (approximately 18 % alcohol by vol-
ume) per week. No significant family history of auto-
immune diseases was noted.
Physical examination findings
On admission, the patient’s vital signs were stable with
blood pressure of 140/80 mmHg, pulse rate of 86 beats/
min, respiratory rate of 20 breaths/min and body
temperature of 37.0 °C. Although the patient showed an
acute ill-looking appearance, his consciousness was clear,
cardiac sound regular, and no heart murmur was heard.
Fine inspiratory crackles were heard at both lower lung
fields. Finger clubbing was not observed, but fingers
were swollen and skin was thickened. The findings in
the abdomen, extremities, and neurological examination
were normal.
Radiological findings
In a plain chest radiograph obtained on admission,
ground glass opacities (GGOs) were observed at the
lower part of both lungs (Fig. 1). In a chest computed
tomography image, reticulation and GGOs were ob-
served in both lungs, leading to the diagnosis of intersti-
tial lung disease (Fig. 2).
Laboratory findings
In arterial blood gas analysis performed before
hospitalization, pH was 7.4; PaCO2, 38 mmHg; PaO2,
94.2 mmHg; and oxygen saturation, 97.3 %. In a periph-
eral blood test, the leukocyte count was 8,300/μL;
hemoglobin, 5.2 g/dL; and platelet count, 436,000/μL. In
a lung function test, findings of restrictive lung function
disorder were obtained with forced vital capacity (FVC)
2.62 L (67 % of the predicted value), forced expiratory
volume in 1 s (FEV1) 2.31 L (80 % of the predicted
value), the ratio of FEV1/FVC 88 %, forced expiratory
flow 25–75 % 4.76 L/sec (154 % of the predicted value),
and peak expiratory flow rate 8.16 L/sec (110 % of the
predicted value).
Clinical progress
The results of bronchoscopy and a lung lavage test re-
vealed chronic inflammation with fibrosis. The results of
lung biopsy were consistent with usual interstitial pneu-
monitis. Breathing difficulty was alleviated with systemic
steroid therapy. During admission, the patient com-
plained of dry mouth and difficulty of swallowing dry
food without liquid. Immune serologic tests were per-
formed under suspicion of autoimmune disease. The re-
sults of serologic tests were as follows; positive for
antinuclear antibody (1:2560), negative for rheumatoid
factor, positive for anti-SSA (Ro) antibody, negative for
anti-SSB (La) antibody and positive for anti-Scl 70 anti-
body. The anti-ds DNA level was 7.64 IU/mL (reference
level, <7.0 IU/mL). The secretory function of the salivary
gland was considered to be decreased. In a salivary gland
scan, the uptake increases in the parotid gland and sub-
mandibular gland were relatively normal; however, the
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ejection fraction of the salivary gland after stimulation
decreased by more than the moderate level. Although
the results of Schirmer’s test did not satisfy the diagnos-
tic criteria for Sjögren’s syndrome, with the right eye
showing a result of 12 mm in 5 min and the left eye
showing a result of 7 mm in 5 min, they were found to
be lower than the normal range. Other diseases such as
hepatitis C, acquired immunodeficiency syndrome,
lymphoma and sarcoidosis were excluded by medical
history and the results of relevant laboratory tests. Clin-
ical findings including ocular symptom of dry eyes, oral
symptom of difficulty in swallowing dry food without
liquid, oral sign of abnormal salivary scintigraphy and
positive autoantibody of anti-SSA (Ro) antibody were
compatible with diagnostic criteria for Sjögren’s syn-
drome (Table 1) [8]. In addition, there were some fea-
tures of systemic sclerosis (puffy fingers, interstitial lung
disease and positive for systemic sclerosis related auto-
antibody [anti-Scl 70]) according to the revised classifi-
cation criteria of systemic sclerosis (Table 2) [9]. The
patient has been followed for the overlap syndrome with
Sjögren’s syndrome and systemic sclerosis.
Occupational history and working environment
The patient had worked for 25 years as a worker in the
large-scale rolling department of a steel-manufacturing
company. He was in charge of maintenance and repairs for
the roughing mill and intermediate mill. His major tasks
were the management of oils, roll exchange of the rolling
mill for different sizes and stand-seating manufacture. Roll-
ing is a plastic process in which the cross-sectional thick-
ness of a material is reduced by successively pressing while
passing it between two rollers. A roughing mill is the first
process where slabs coming out of the furnace are rolled,
and this produces dust containing silica. Hot rolling is a
rolling process performed at a temperature of between
1100 °C and 1200 °C. A large amount of fumes develops at
that high temperature. Generally, the hot rolling process is
a wet process. As it progresses, oxidized film on the surface
of the rolled material is removed and water is jet-sprayed to
prevent the high generation of fumes. The final product is a
scroll-shaped intermediate processed product called a coil,
after which additional processing is performed in the cold
rolling process. The large-scale milling process in which he
was involved is a series of operations comprising the fur-
nace, roughing mill, intermediate mill, finishing mill and
cutting. The roll was being exchanged for different sizes
more than once a day, depending on the work volume. To
meet the production standards when changing the roll, the
process of resting the new roll on a stand, dissembling the
existing roll and performing the exchange was mainly per-
formed near the rolling mill owing to the nature of the
work. According to the report of working environment
measurement, noise, dust, toxic metals and heat were
Fig. 1 A chest radiograph. Ground glass opacities are seen in both lower lung fields
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identified as occupational hazards. In general, workers in
the milling process take 30-min rest after 30-min working
because of the high-heated working condition. The patient
has worked on the three-shift system. The total ventilation
system was applied in the plant, and the patient has regu-
larly used personal protective equipment including mask
and ear plugs.
It was verified that standard steel products produced by a
series of hot rolling processes contain a maximum of 0.4 %
silicon [10]. However, the concentration of free silica in the
air was not measured directly. Instead, type 2 dust, which
contains silicon dioxide up to 30 %, was measured as min-
eral dust. According to the report of working environment
measurement in 2008, the concentration of type 2 dust was
1.444 mg/m3 and 0.417 mg/m3 in the roughing and inter-
mediate mills, respectively (Table 1). Potential toxic sub-
stances other than silica were found in the milling process
such as nickel, chromium and manganese, but the ambient
concentration was very low or not detectable. For example,
the highest concentration of nickel and manganese were
measured at the roughing mill site, which were 0.0026 mg/
m3 and 0.0051 mg/m3, respectively (Table 3).
Discussion
The current case satisfied the diagnostic criteria for
Sjögren’s syndrome owing to the conditions of ocular
Fig. 2 Chest computed tomography images. Peribronchial and subpleural reticulation and ground glass opacities are seen in both lungs,
predonminantly in the lower parts of the lungs
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symptoms (dry eyes for several months), oral symptoms
(need liquids to swallow dry foods), salivary gland infil-
tration (abnormal salivary scintigraphy) and presence of
anti-SSA (Ro) antibody in the serum. Diagnosis of sys-
temic sclerosis is based on the scoring system revised in
2013 by the American college of rheumatology and the
European league against rheumatism. Patients with a total
score of 9 or higher are classified as having definite sclero-
derma. In this case, the patient had puffy fingers, interstitial
lung disease and anti-Scl 70 antibody. The patient had clin-
ical findings compatible with systemic sclerosis although
the total score of 7 was insufficient to classify as having
definite systemic sclerosis. Actually, the nailfold capillaro-
scopy was performed at other medical institute and the re-
sult was abnormal. If there were abnormal findings in
nailfold capillaries, definite diagnosis of systemic sclerosis
would be possible with total score of 9. Unfortunately, we
could not obtain the figures of the nailfold capillaroscopy,
but only the written interpretations.
Silica exposure and autoimmune diseases in the previous
literature
The association between silica exposure and autoimmune
diseases was first reported by Caplan in 1953. It was
proposed with regard to the characteristic chest radio-
graphic findings in miners with rheumatoid arthritis [11].
Later, it was called Caplan’s syndrome in several reports,
including from Korea [12, 13]. Systemic sclerosis was first
described by Erasmus in 1957, after which additional
reports described it as Erasmus syndrome [14, 15]. Sys-
temic lupus erythematosus (SLE) was reported by Conrad
in 1996 in a uranium mine cohort study, and Yamazaki
reported a case in 2007 in which short exposure for a few
months caused SLE in miners [16, 17]. In a prospective
study by Sanchez-Roman in 1993 on 50 workers exposed
to silica, systemic diseases were found in 64 % of the
workers (Table 4), among which three cases of Sjögren’s
syndrome were diagnosed as primary Sjögren’s syndrome
[18]. Later, five additional cases were reported, and the
disease was considered to be rare [5, 19, 20].
Association between silica exposure and autoimmune
diseases
Many cases of autoimmune diseases caused by exposure
to silica have been identified during testing or treatment
for silicosis. It is still unclear whether silicosis is a simple
marker of silica exposure or presents the pathogenesis of
autoimmune diseases. When silica particles enter the
respiratory system, they are phagocytized by alveolar mac-
rophages and activate inflammatory responses and fibro-
blasts [21]. Silica is cytotoxic, and silica particles cannot be
degraded by the lysosomal enzymes of macrophages. It
induces fibrosis through immune activation and chronic
stimulation of macrophages leading to silicosis, and can be
transported to other organs including the lymph nodes,
spleen and kidney [22]. In a study on rats exposed to silica,
pathological changes without fibrosis were observed in the
lymph nodes [23]. The effects on the lymphatic system can
be explained by immune reactions related to the early
exposure to silica. Silica-mediated antibody production is
known to be induced after the secretion of several cytokines
and fibrogenic factors with repeated mobilization and death
of macrophages. In this process, inflammatory cells are
activated; activated reactive oxygen is produced; tissue
reactions occur in the lung parenchyma; and inflammatory
mediators such as tumor necrosis factor-α, platelet
Table 1 Diagnostic criteria for Sjögren’s syndrome
(American-European Consensus for Sjögren’s syndrome [8])
Criteriaa
I. Ocular symptoms (at least one)
1. Dry eyes for at least 3 months
2. A foreign body sensation in the eyes
3. Use of artificial tears three or more times per day
II. Oral symptoms (at least one)
1. Dry mouth for at least 3 months
2. Recurrent or persistently swollen salivary glands
3. Need for liquids to swallow dry foods
III. Ocular signs (at least one)
1. Abnormal Schimer’s test
(5 mm or less in 5 min)
2. Positive vital dye staining
(van Bijsterveld score 4 or higher)
IV. Histopathology
1. Lip biopsy showing focal lymphocytic sialoadenitis
(focus score ≥1 per 4 mm2)
V. Oral signs (at least one)
1. Unstimulated whole salivary flow
(1.5 ml or less in 15 min)
2. Abnormal parotid sialography
3. Abnormal salivary scintigraphy
VI. Autoantibodies (at least one)
1. Anti-SSA (Ro) or anti-SSB (La) or both
VII. Exclusion criteria
1. Past head and neck radiation treatment
2. Hepatitis C infection
3. Acquired immunodeficiency syndrome
4. Pre-existing lymphoma
5. Sarcoidosis
6. Graft versus host disease
7. Current use of anticholinergic drugs
aFor primary Sjögren’s syndrome, (i) any 4 of the 6 criteria, must include either
item IV (histopathology) or VI (autoantibodies) or (ii) any 3 of the 4 objective
criteria (III, IV, V, VI); for secondary Sjögren’s syndrome, in patients with
another well-defined major connective tissue disease, the presence of one
symptom (I or II) plus 2 of the 3 objective criteria (III, IV and V)
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derived growth factor, and interleukin(IL) are pro-
duced [24, 25]. IL-1 activates T-helper cells and pro-
motes antibody production in B-cells [26]. Silica also
activates the immune processes that produce reactive
oxygen and nitrogen [27, 28]. This adjuvant effect is
consistent with the hypothesis that silica causes auto-
immunity and can be the cause of cell death through
necrosis [29]. The mechanism by which silica expos-
ure causes autoimmunity has been described in the
literature, and it involves the repeated mobilization
and death of macrophages in response to free silica
entering the body through the respiratory system,
resulting in the production of various cytokines and
fibrogenic factors, which causes autoimmunity. Add-
itionally, inflammatory mediators trigger the depos-
ition of neutrophils that secret lytic enzymes, destroy
the lung parenchyma, and induce proliferation of fi-
broblasts, thereby causing irreversible lung fibrosis,
activating helper T cells, and accelerating antibody
production in B-cells, which eventually results in the
induction of autoimmune diseases.
The concentration of silica could not been measured
directly in this study. We tried to measure the ambient
concentration of silica, however, there were technical limi-
tations and noncooperation of the worksite. However, ex-
posure to silica could be estimated rationally. First, there
were silica-containing additives such as ferrosilicon (FeSi)
and silicomanganese (SiMn). FeSi is an additive used to
add silicon to iron, and it is the cheapest and most effect-
ive deoxidizer and desulfurizing agent. It is classified into
FeSi45, FeSi65, and FeSi75 depending on the silicon con-
tent, with FeSi75 being used the most. FeSi is added to
section steel or reinforcing steel bars to increase the
strength and hardness of steel. It is added to structural
steel at up to 0.4–1.8 %. SiMn is used to add manganese
to section steel, and it contains up to 14–25 % silicon. Sili-
con content of hot rolled H-beam for building structure
sold in the domestic market was found to be 0.18–0.24 %,
although the result differed for each specimen [10]. Sec-
ond, oxidized silica can be released into the air from the
surface of heated steel. The Deal-Grove model explains
the thermal oxidation mechanism of silica, in which the
following three processes occur: diffusion from the ambi-
ent gas layer to the oxide surface, diffusion through the
oxide layer to the substrate interface, and reaction with
the substrate [30]. In a 1200 °C wet process such as the
hot rolling process, 0.2 μm thickness of SiO2 is produced
per 0.1 h of exposure. Although silica was not directly
measured at the workplace, the production of silica in the
hot rolling process was confirmed, and actual exposure
could be reasonably inferred considering the working en-
vironment of the patient.
The subjects of previous reports about the association
between silica exposure and autoimmune diseases were
Table 2 Diagnostic criteria for systemic sclerosis (American
College of Rheumatology/European League Against Rheumatism
criteria for the classification of systemic sclerosis [9])
Item Sub-items Weight/scorea
Skin thickening of the





Skin thickening of the
fingers (only count the
higher score)
Puffy fingers
Sclerodactly of the fingers
(distal to the metacarpop
halangeal joints but
































aThe total score is determined by adding the maximum weight (score) in each
category. Patients with a total score of 9 or higher are classified as having
definite scleroderma
Table 3 The results of working environment measurement for dusts in rolling mill part
Survey year Type of dust Site Concentration (mg/m3) Exposure limit (mg/m3)
2008 Type 2 dusta Roughing mill 1.444 5
Intermediate mill 0.417
Finishing mill 0.556
2013 Unspecified mineral dustb Roughing mill 1.349 10
Intermediate mill 0.841
Finishing mill 2.384
aType 2 dust contains silicon dioxide up to 30 %
bUnspecified mineral dust contains silicon dioxide up to 1 %
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from relatively high-level exposure occupational group
such as coal miners. In this study, the patient seemed to
be exposed to relatively low level of silica dust. It is un-
clear that long-term low-level exposure to silica causes
or induces autoimmune diseases. Although the results of
previous experimental study suggest that the inflamma-
tory response in silicosis is dose dependent to silica expos-
ure [31], there has been lack of data about the dose–
response relationship between silica exposure and auto-
immune diseases. Moreover, the findings about the dose–
response relationship of silicosis were derived from an ani-
mal model. It seems that there may be genetic differences
and susceptibility to autoimmune disease. Another study
reported that silica might have both immediate and latent
effects, suggesting that low-level exposure could promote
the development of autoimmune diseases [32]. Further in-
vestigations about the association between silica exposure
and autoimmune diseases under low exposure to silica
dust should be encouraged.
There were limited evidence about the association
between autoimmunity and heavy metals including
nickel [33], while cobalt is known to be associated
with interstitial lung disease, so-called hard metal
lung disease [34]. Moreover, hard metal lung disease
is associated with giant cell interstitial pneumonitis in
pathologic characteristics, which is distinguished from
usual interstitial pneumonitis [34]. However, the re-
sults should be interpreted with caution because there
were some limitations including no direct measure-
ment of silica concentration and uncertainty of the
relationship between low dose silica exposure and the
development of autoimmune diseases.
There were 36 co-workers in the rolling mill process in
2008. They could be classified into similar exposure group
according to the nature of their job and the results of work-
ing environment measurement. Based on the results of
regular health examination, co-workers were not suspicious
having occupational diseases except noise-induced hearing
loss. Considering that autoimmune disease is uncommon
disease itself and affects women more frequently than men,
it is hard to exclude the association between silica exposure
and the patient’s clinical manifestation in this case.
Conclusion
Occupational exposure to silica seemed to be associated
with the patient’s clinical manifestations of overlap
syndrome with Sjögren’s syndrome and systemic scler-
osis. Although the underlying mechanism is still unclear,
the facts that there were no family history of auto-
immune disease and no other relevant hazardous mate-
rials associated with the patient’s clinical manifestations
support there was an association between occupational
silica exposure and the disease of the patient. Future re-
search about the association between long-term low
dose exposure to silica and the development of auto-
immune diseases should be encouraged.
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